AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts. (Q45976110)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts. |
scientific article |
Statements
1 reference
AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts. (English)
1 reference
Kate F Byth
1 reference
Andrew Thomas
1 reference
Gareth Hughes
1 reference
Cheryl Forder
1 reference
Alexandra McGregor
1 reference
Catherine Geh
1 reference
Sandra Oakes
1 reference
Clive Green
1 reference
Mike Walker
1 reference
Nicholas Newcombe
1 reference
Stephen Green
1 reference
Jim Growcott
1 reference
Andy Barker
1 reference
Robert W Wilkinson
1 reference
9 June 2009
1 reference
1 reference
8
1 reference
1856-1866
1 reference
7
1 reference
Identifiers
1 reference
1 reference